LEVEL: Intermediate
Continuing Education Eligibility (Included):
BACB: 14 Learning
QABA: 14 General (In-person)
APA: 14 General (Home Study)
Providers of Healthcare or education serving the needs of individuals with Autism or other special needs encounter medication-related issues on a daily basis. Virtually every professional (and parents) understand that medication plays a significant factor in a person’s ability to function and make progress, but very few possess sufficient levels of knowledge to make informed decisions when providing services to children, adolescents, and adults receiving medication. This lack of knowledge is even more pronounced when dealing with co-morbid conditions.
SL Global’s Psychopharmacology series, with Dr. Ronald T. Brown and Dr. Debbie Coehlo, is designed to provide educators, healthcare providers, and parents with a comprehensive understanding of psychopharmacology and its impact on various childhood disorders.
This series will start with a comprehensive overview of medication and childhood disorders. Subsequent modules will provide a deeper understanding of psychopharmacology as it pertains to specific conditions, including ADHD, Autism, and other Mood Disorders. The series will conclude with sessions on Evidence-based practices, Ethics of Medication, and a deeper look at assessing and diagnosing individuals with various conditions.
Each 2-hour session will be broken down into three primary areas: (1) study on classes of medication; (2) how it relates to various symptoms; and (3) use of case studies to provide a deeper level of understanding by seeing how both come together in practice.
Each LIVE Webinar will be 2 hours in length. Each LIVE Webinar will be broadcasted from 12 pm to 2 pm Central.
This 7-part series includes the following titles:
- Overview of Psychopharmacology and Childhood Disorders: March 10, 2021
- Psychopharmacology and ADHD: April 14, 2021
- Psychopharmacology and Autism: May 12, 2021
- Psychopharmacology and Mood Disorders: June 9, 2021
- Psychopharmacology and Evidence-Based Practices: July 14, 2021
- Ethics of Medication: August 11, 2021
- Psychopharmacology: Diagnosis and Assessment: September 8, 2021